NLS-RARα contributes to differentiation block and increased leukemogenic potential in vivo

Cell Signal. 2020 Jan:65:109431. doi: 10.1016/j.cellsig.2019.109431. Epub 2019 Oct 22.

Abstract

The fusion oncogene, promyelocytic leukemia (PML)-retinoic acid receptor-α (RARα), is crucial for acute promyelocytic leukemia (APL) pathogenesis. Previous studies have reported that PML-RARα is cleaved by neutrophil elastase (NE), an early myeloid-specific serine protease, leading to translocation of the nuclear localization signal (NLS) of the PML protein to the N-terminal of RARα. This study was designed to evaluate the value of NLS-RARα in the early diagnosis of APL. To investigate the potential functional role of NLS-RARα in leukemogenesis, HL-60 and U937 cell lines were transfected with NLS-RARα lentivirus and negative control (LVNC). The results showed that the induced expression of NLS-RARα down-regulated expressions of CD11b, CD11c, and CD14 compared to the LVNC group induced by 1α, 25-dihydroxyvitamin D3(1,25(OH)2D3). This suggested that NLS-RARα overexpression inhibited granulocytic and monocytic differentiation of myeloid leukemia cells. In addition, Wright-Giemsa staining, flow cytometry, respiratory burst assay, and NBT reduction assay all confirmed the importance of NLS-RARα in differentiation. The mechanistic investigations revealed that induced NLS-RARα expression inhibited 1,25(OH)2D3-induced granulocytic differentiation by regulating the cell cycle regulators p19INK4D, p21WAF1/CIP1, cyclinD1, cyclin E1, and pRB. Furthermore, the cleaved protein NLS-RARα enhanced the oncogenicity of U937 cells in NOD/SCID mice. These findings collectively demonstrated that NLS-RARα blocked granulocytic and monocytic differentiation of myeloid leukemia cells by inhibiting the downstream targets of the RARα signal pathway and the cell cycle. This may provide a promising new target and method for diagnosing and treating APL.

Keywords: APL; Cell cycle; Differentiation; NLS-RARα; Target diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcitriol / pharmacology
  • Carcinogenesis / drug effects
  • Carcinogenesis / pathology*
  • Cell Cycle / drug effects
  • Cell Differentiation* / drug effects
  • Cell Line, Tumor
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / pathology*
  • Mice, Inbred NOD
  • Mice, SCID
  • Nuclear Localization Signals / metabolism*
  • Retinoic Acid Receptor alpha / chemistry*
  • Retinoic Acid Receptor alpha / metabolism*
  • Structure-Activity Relationship

Substances

  • Nuclear Localization Signals
  • Retinoic Acid Receptor alpha
  • Calcitriol